Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-30 @ 3:52 PM
Study NCT ID:
NCT05171335
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2022-09-21
First Post:
2021-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
Sponsor:
The Methodist Hospital Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-10
First Submit QC Date:
None
Study First Post Date:
2021-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-15
Last Update Post Date:
2022-09-21
Last Update Post Date Type:
ACTUAL